TP53 suppression promotes erythropoiesis in del(5q) MDS, suggesting a targeted therapeutic strategy in lenalidomide-resistant patients

Tekijä Caceres, Gisela, McGraw, Kathy, Yip, Bon Ham, Pellagatti, Andrea, Johnson, Joseph, Zhang, Ling, Liu, Kenian, Zhang, Lan Min, Fulp, William J., Lee, Ji-Hyun, Al Ali, Najla H., Basiorka, Ashley, Smith, Larry J., Daugherty, F. Joseph, Littleton, Neil, Wells, Richard A., Sokol, Lubomir, Wei, Sheng, Komrokji, Rami S., Boultwood, Jacqueline, List, Alan F.
Julkaistu 2013